News & Events

Fortis Life Sciences Acquires nanoComposix

July 23, 2021

Fortis Life Sciences has completed its acquisition of nanoComposix, a premiere nanomaterials company focused on solutions for assay development and diagnostics. Since 2004, nanoComposix has built one of the most comprehensive nanomaterials portfolios in the industry. nanoComposix’s nanomaterials are used in a wide array of Life Sciences applications, including drug delivery, diagnostics and imaging, as well as industrial applications.

Continue Reading




Fortis Life Sciences Acquires Bethyl Laboratories

March 10, 2021

Fortis Life Sciences, a life sciences company offering products and solutions for the life sciences industry, has acquired the premium antibody company Bethyl Laboratories. Based in Montgomery, Texas, Bethyl Laboratories has a long history of offering the highest quality primary and secondary antibodies to its customers, as well as other protein detection reagents. Bethyl Laboratories is well known for industry leading performance and the highest standards in antibody validation, and prior to the acquisition by Fortis, had successfully operated as a private, family-owned, and operated business for nearly 50 years.

Continue Reading




Biocare Medical and Bethyl Laboratories Announces the Launch of TIGIT IVD Rabbit Monoclonal Antibody for Immunohistochemical Applications

Biocare Medical - August 4, 2020

Continue Reading




Biocare Medical and Bethyl Laboratories Announce Strategic Partnership for Antibody Development

Biocare Medical - June 29, 2020

Continue Reading




New Collaboration with Bethyl Laboratories Expands Antibody Offerings for Hyperion Imaging System

Fluidigm - June 17, 2020

Continue Reading

Stay in the know!

Sign up to receive the latest news and information from Fortis Life Sciences.


Sign Up